HOME >> BIOLOGY >> NEWS
Proteomics and alcoholism research

"Proteomics" refers to the study of proteins that are synthesized by cells, tissues and organs in the body. Recent advances in technology now allow scientists to separate and identify these proteins. According to symposium proceedings published in the February issue of Alcoholism: Clinical & Experimental Research, proteomics has important implications for alcoholism research in terms of identifying biomarkers of alcohol intake, understanding alcohol's effects, particularly on the liver, and developing drugs to treat alcoholism.

"The study of proteins involved in alcoholism has taken two different approaches," said Chinnaswamy Kasinathan, associate professor at the University of Medicine and Dentistry of New Jersey and symposium organizer. "One approach is to select a protein for study because of its role in a pathway believed to involve alcoholism. Since alcoholism is a behavioral disorder, many of the candidate proteins selected for study are involved in neurochemical pathways. An alternate proteomic approach is to study as many proteins as can be separated by a technique such as 2D gel electrophoresis and identified through mass spectrometry. This approach does not select any candidate protein in advance, rather, this approach incorporates and examines the entire proteosome of the body."

The symposium took place at the June 2003 Research Society on Alcoholism meeting in Fort Lauderdale, Florida. Some of the key points were:

  • Research designed to identify a urinary biomarker for alcohol intake has found the presence of two groups of proteins in the urine of alcohol-treated rats but not in the urine of control animals.

    "The ultimate goal of this research is to apply the animal findings to the development of good urinary biomarkers in humans as a measure of alcohol intake," said Kasinathan.

    "This would have important applications for many alcoholism treatment facilities," he added. "For example, there are a
    '"/>




  • 15-Feb-2004


    Page: 1 2 3

    Related biology news :

    1. Proteomics drives new generation of medical treatment
    2. Consortium for Archaeal Genomics and Proteomics established at Penn State
    3. A liking for sweets, combined with novelty seeking, may predict alcoholism
    4. Acamprosate: potential medication for treating alcoholism
    5. Gene linked to alcoholism
    6. Gene therapy reduces drinking in rats with genetic predisposition to alcoholism
    7. A sweet tooth may be a marker for the genetic risk for developing alcoholism
    8. Adult alcoholism and attention-deficit hyperactivity disorder are connected
    9. Researchers find three chromosomal areas with links to alcoholism vulnerability
    10. The eyes have it: Seeking expressions of the genetic risk for developing alcoholism
    11. Investigating a protective gene against alcoholism

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... priced an offering of €500.0 million principal amount of its ... amount of its 2.425% senior unsecured notes due 2026. ... occur on December 13, 2016, subject to the satisfaction of customary ... basis. The Company intends to ...
    (Date:12/2/2016)...   SoftServe , a global digital technology ... electrocardiogram (ECG) biosensor analysis system for continuous driver ... The smart system ensures device-to-device communication between ECG ... mobile devices to easily ,recognize, and monitor users ... technology advances, so too must the security systems ...
    (Date:11/29/2016)... , November 29, 2016 Nearly one billion matches ... Reading ... DERMALOG ... of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ...
    Breaking Biology News(10 mins):
    (Date:12/8/2016)... ... December 08, 2016 , ... Opal ... provide essential device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, the ... FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard 204-pin SODIMM ...
    (Date:12/8/2016)... ... December 08, 2016 , ... ... exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This single ... engineered to radically streamline culture processes, minimize processing time, significantly decrease production ...
    (Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. ... discovers, develops and plans to commercialize innovative therapeutics ... of common stock were approved for trading on ... trading on the OTCQX, effective today, under the ... the OTCQX market, companies must meet high financial ...
    (Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
    Breaking Biology Technology:
    Cached News: